CNO
Overvalued by 1.7% based on the discounted cash flow analysis.
Market cap | $3.04 Billion |
---|---|
Enterprise Value | $6.94 Billion |
Dividend Yield | $0.5949 (2.12%) |
Earnings per Share | $3.47 |
Beta | 0.9 |
Outstanding Shares | 108,259,664 |
Avg 30 Day Volume | 637,214 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 7.81 |
---|---|
PEG | -0.06 |
Price to Sales | 0.72 |
Price to Book Ratio | 1.34 |
Enterprise Value to Revenue | 1.62 |
Enterprise Value to EBIT | 13.76 |
Enterprise Value to Net Income | 17 |
Total Debt to Enterprise | 0.56 |
Debt to Equity | 1.65 |
No data
No data